China to 'gift' 0.5m doses of Covid-19 vaccine to Pakistan by Jan 31: Qureshi.

ISLAMABAD -- Foreign Minister Shah Mehmood Qureshi has announced that China has promised to provide 500,000 doses of a coronavirus vaccine to Pakistan by January 31.

In a video message after a phone call with his Chinese counterpart Wang Yi, Qureshi said China offered Islamabad to send an airplane and airlift the vaccines.

The minister said he held a detailed conversation with the Chinese foreign minister in which he "discussed Pakistan's requirements", after Prime Minister Imran Khan had directed him to increase interaction with Beijing "considering the sensitivity of the situation".

"I want to give the nation the good news that China has promised to immediately provide 500,000 doses of vaccine to Pakistan by January 31," he said.

"They (China) have said you can send your airplane and immediately airlift this drug," he added, saying the development would "help save many lives" in Pakistan.

In a tweet, Qureshi suggested the doses to be provided to Pakistan will be of the Sinopharm vaccine, which the Drug Regulatory Authority of Pakistan (Drap) had approved for emergency use in the country earlier this week.

"With encouraging results of Chinese vaccine and our historic relationship, Pakistan has approved emergency use authorisation of SinoPharm [vaccine]. Indeed Pakistan greatly appreciates the 500,000 doses of the vaccine gifted by China," he wrote.

The vaccine was developed by the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced last month that preliminary data from last-stage trials had shown it to be 79.3 per cent effective.

But Qureshi said he informed his Chinese counterpart that Pakistan's requirement for vaccines is "more than this", and that it will need 1.1 million doses in the near future.

"At...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT